Modular Medical
MODD
12 hedge funds and large institutions have $2.21M invested in Modular Medical in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more funds holding
Funds holding: 12 → 12 (0)
0.02% less ownership
Funds ownership: 0.48% → 0.47% (-0.02%)
30% less capital invested
Capital invested by funds: $3.17M → $2.21M (-$956K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.91K |
| 3 |
BlackRock
New York
|
+$1.09K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$682 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$140K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$68 |
MODD Hedge Fund Activity: Q1 2023 in Review
12 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Modular Medical (MODD) for Q1 2023, worth a combined $2.21M — down 30% from $3.17M a quarter earlier.
Fund positioning in MODD was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Millennium Management, adding an estimated $3K. The largest seller was Opaleye Management, cutting an estimated $140K.
- 12 institutional investors held Modular Medical (MODD) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $2.21M of Modular Medical stock for Q1 2023, down 30% quarter-over-quarter.
- 0 funds opened new Modular Medical positions in Q1 2023 and 0 closed out.
- The largest Modular Medical buyer in Q1 2023 was Millennium Management, an estimated $3K added.
- The largest Modular Medical seller in Q1 2023 was Opaleye Management, an estimated $140K sold.
Based on aggregated 13F filings for Q1 2023.